secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2023-10-03T23:59:59+00:00
Accession:  0001640334-23-001769
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria raises $1.57M in registered direct offering and private placement
-------------------------------------------------------------------------

- Gross proceeds of $1.57M from sale of 889,272 shares at $0.97, pre-funded warrants for 729,058 shares at $0.9699, and private placement warrants for 1,618,330 shares at $0.97.
- Placement agent Maxim Group LLC receives 7% cash fee; offering closed October 3, 2023.
- Net proceeds to be used for R&D studies, patent costs, and general working capital.
- Officers and directors subject to 30-day lock-up from September 28, 2023.
- Private placement warrants exercisable after 6 months, expire 5.5 years; pre-funded warrants exercisable immediately.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033423001769/0001640334-23-001769-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033423001769/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-23-001769

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer